Zahlungsmittel Und Äquivalente Veränderung Datum
3M USD 2.96B 774M 2026-06
Abbott USD 6.8B 1.72B 2026-03
AngioDynamics USD 41.64M 14.26M 2025-09
Anika Therapeutics USD 38.41M 2.61M 2026-06
AtriCure USD 167.79M 21.62M 2026-06
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 813M 73M 2026-03
Boston Scientific USD 539M 914M 2026-06
Cooper Companies USD 124.9M 14.3M 2025-12
Dexcom USD 1.1B 13.2M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Globus Medical USD 560.95M 34.79M 2026-03
Haemonetics USD 245.44M 117.93M 2026-03
ICU Medical USD 307.96M 8.23M 2025-12
Insulet USD 480.4M 235.7M 2026-03
Integra LifeSciences USD 214.42M 22.39M 2026-06
J&J USD 20.42B 1.27B 2026-06
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 448.7M 39.38M 2026-06
Olympus JPY 147.24B 93.98B 2025-09
Pfizer USD 976M 727M 2026-06
STAAR Surgical USD 153.15M 23M 2025-12
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 179.32M 88.69M 2026-03
Teleflex USD 309.41M 69.15M 2026-03
Terumo JPY 217.16B 12.86B 2025-09
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03